Professor Camiel J. F. Bonn supervised a review article presenting the currently available options to manage retinitis pigmentosa (RP). RP causes a gradual loss of visual function due to the degeneration of photoreceptors, with an individual-specific clinical course that is hard to predict. Although RP is untreatable for the majority of patients, several gene therapies have recently been proposed, offering new hope for the treatment of patients affected by inherited retinal dystrophies. The article familiarizes the reader with these gene therapies, as well as the supportive management options, to provide some relief of the physical, mental and social-emotional burden that patients may experience.